Literature DB >> 24942926

Interferon controls SUMO availability via the Lin28 and let-7 axis to impede virus replication.

Umut Sahin1, Omar Ferhi1, Xavier Carnec1, Alessia Zamborlini2, Laurent Peres1, Florence Jollivet1, Adeline Vitaliano-Prunier1, Hugues de Thé3, Valérie Lallemand-Breitenbach1.   

Abstract

Small ubiquitin-related modifier (SUMO) protein conjugation onto target proteins regulates multiple cellular functions, including defence against pathogens, stemness and senescence. SUMO1 peptides are limiting in quantity and are thus mainly conjugated to high-affinity targets. Conjugation of SUMO2/3 paralogues is primarily stress inducible and may initiate target degradation. Here we demonstrate that the expression of SUMO1/2/3 is dramatically enhanced by interferons through an miRNA-based mechanism involving the Lin28/let-7 axis, a master regulator of stemness. Normal haematopoietic progenitors indeed display much higher SUMO contents than their differentiated progeny. Critically, SUMOs contribute to the antiviral effects of interferons against HSV1 or HIV. Promyelocytic leukemia (PML) nuclear bodies are interferon-induced domains, which facilitate sumoylation of a subset of targets. Our findings thus identify an integrated interferon-responsive PML/SUMO pathway that impedes viral replication by enhancing SUMO conjugation and possibly also modifying the repertoire of targets. Interferon-enhanced post-translational modifications may be essential for senescence or stem cell self-renewal, and initiate SUMO-dependent proteolysis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24942926     DOI: 10.1038/ncomms5187

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  26 in total

Review 1.  PML nuclear bodies: assembly and oxidative stress-sensitive sumoylation.

Authors:  Umut Sahin; Hugues de Thé; Valérie Lallemand-Breitenbach
Journal:  Nucleus       Date:  2014       Impact factor: 4.197

2.  Stability of HTLV-2 antisense protein is controlled by PML nuclear bodies in a SUMO-dependent manner.

Authors:  Louise Dubuisson; Florence Lormières; Stefania Fochi; Jocelyn Turpin; Amandine Pasquier; Estelle Douceron; Anaïs Oliva; Ali Bazarbachi; Valérie Lallemand-Breitenbach; Hugues De Thé; Chloé Journo; Renaud Mahieux
Journal:  Oncogene       Date:  2018-03-06       Impact factor: 9.867

Review 3.  SUMO and the robustness of cancer.

Authors:  Jacob-Sebastian Seeler; Anne Dejean
Journal:  Nat Rev Cancer       Date:  2017-01-30       Impact factor: 60.716

4.  Promyelocytic Leukemia Protein (PML) Requirement for Interferon-induced Global Cellular SUMOylation.

Authors:  Mohamed Ali Maroui; Ghizlane Maarifi; Francis P McManus; Frédéric Lamoliatte; Pierre Thibault; Mounira K Chelbi-Alix
Journal:  Mol Cell Proteomics       Date:  2018-03-13       Impact factor: 5.911

Review 5.  Sumoylation in Physiology, Pathology and Therapy.

Authors:  Umut Sahin; Hugues de Thé; Valérie Lallemand-Breitenbach
Journal:  Cells       Date:  2022-02-26       Impact factor: 6.600

6.  Identification of c-MYC SUMOylation by mass spectrometry.

Authors:  Manpreet Kalkat; Pak-Kei Chan; Amanda R Wasylishen; Tharan Srikumar; Sam S Kim; Romina Ponzielli; David P Bazett-Jones; Brian Raught; Linda Z Penn
Journal:  PLoS One       Date:  2014-12-18       Impact factor: 3.240

7.  Shigella infection interferes with SUMOylation and increases PML-NB number.

Authors:  Saima M Sidik; Jayme Salsman; Graham Dellaire; John R Rohde
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

8.  Promyelocytic Leukemia Protein (PML) Controls Listeria monocytogenes Infection.

Authors:  David Ribet; Valérie Lallemand-Breitenbach; Omar Ferhi; Marie-Anne Nahori; Hugo Varet; Hugues de Thé; Pascale Cossart
Journal:  mBio       Date:  2017-01-10       Impact factor: 7.867

9.  Novel Role for Protein Inhibitor of Activated STAT 4 (PIAS4) in the Restriction of Herpes Simplex Virus 1 by the Cellular Intrinsic Antiviral Immune Response.

Authors:  Kristen L Conn; Peter Wasson; Steven McFarlane; Lily Tong; James R Brown; Kyle G Grant; Patricia Domingues; Chris Boutell
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

10.  Role of SUMO activating enzyme in cancer stem cell maintenance and self-renewal.

Authors:  Li Du; Yi-Jia Li; Marwan Fakih; Rebecca L Wiatrek; Marjun Duldulao; Zhenbin Chen; Peiguo Chu; Julio Garcia-Aguilar; Yuan Chen
Journal:  Nat Commun       Date:  2016-07-28       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.